Evidence map›Paper›PMID 32677899›Full record

ArticleBMC infectious diseases2020

Polymorphisms of pfcrt, pfmdr1, and K13-propeller genes in imported falciparum malaria isolates from Africa in Guizhou province, China.

Danya She, Zhengyan Wang, Qiuguo Liang, Lidan Lu, Yuting Huang, Ke Zhang, Dong An, Jiahong Wu

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. A review of malaria molecular markers for drug resistance inFrontiers in cellular and infection microbiology · 2023
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Danya SheKey Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University; Department of Parasitology; Provincial Key Laboratory of Modern Pathogen Biology, Guizhou Medical University, Guiyang, 550025, China.
Zhengyan WangKey Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University; Department of Parasitology; Provincial Key Laboratory of Modern Pathogen Biology, Guizhou Medical University, Guiyang, 550025, China.
Qiuguo LiangKey Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University; Department of Parasitology; Provincial Key Laboratory of Modern Pathogen Biology, Guizhou Medical University, Guiyang, 550025, China.
Lidan LuGuizhou Provincial Center for Disease Control and Prevention, Guiyang, 550004, China.
Yuting HuangGuizhou Provincial Center for Disease Control and Prevention, Guiyang, 550004, China.
Ke ZhangKey Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University; Department of Parasitology; Provincial Key Laboratory of Modern Pathogen Biology, Guizhou Medical University, Guiyang, 550025, China.
Dong AnGuizhou Provincial Center for Disease Control and Prevention, Guiyang, 550004, China.
Jiahong WuKey Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University; Department of Parasitology; Provincial Key Laboratory of Modern Pathogen Biology, Guizhou Medical University, Guiyang, 550025, China. jiahongwu2008@hotmail.com.ORCID http://orcid.org/0000-0001-6453-1570
Guiyang Medical University · CNGuizhou Center for Disease Control and Prevention · CN

Funding

Project of Basic Science and Technology Platform in Guizhou Province No. 2012[4006]
6 · The paper itself

Abstract

backgroundImported falciparum malaria from Africa has become a key public health challenge in Guizhou Province since 2012. Understanding the polymorphisms of molecular markers of drug resistance can guide selection of antimalarial drugs for the treatment of malaria. This study was aimed to analyze the polymorphisms of pfcrt, pfmdr1, and K13-propeller among imported falciparum malaria cases in Guizhou Province, China.

methodFifty-five imported falciparum malaria cases in Guizhou Province during 2012-2016 were included in this study. Their demographic information and filter paper blood samples were collected. Genomic DNA of Plasmodium falciparum was extracted from the blood samples, and polymorphisms of pfcrt, pfmdr1, and K13-propeller were analyzed with nested PCR amplification followed by sequencing. Data were analyzed with the SPSS17.0 software.

resultsThe prevalence of pfcrt K76T, pfmdr1 N86Y, and pfmdr1 Y184F mutation was 56.6, 22.2, and 72.2%, respectively, in imported falciparum malaria cases in Guizhou Province. We detected two mutant haplotypes of pfcrt, IET and MNT, with IET being more commonly found (54.7%), and five mutant haplotypes of pfmdr1, of which NFD was the most frequent (53.7%). There were totally 10 combined haplotypes of pfcrt and pfmdr1, of which the haplotype IETNFD possessed a predominance of 28.8%. In addition, three nonsynonymous mutations (S459T, C469F, and V692L) and two synonymous mutations (R471R and V589V) were detected in K13-propeller, all having prevalence less than 6.0%. In particular, a candidate K13 resistance mutation, C469F, was identified for the first time from Democratic Republic of the Congo with the prevalence of 2.0%.

conclusionsThe high prevalence of IET haplotype of pfcrt and NFD haplotype of pfmdr1 suggests the presence of chloroquine, artemether/lumefantrine, and dihydroartemisinin/piperaquine resistance in these cases. Therefore cautions should be made to artemisinin therapy for P. falciparum in Africa. Continuous monitoring of anti-malarial drug efficacy in imported malaria cases is helpful for optimizing antimalarial drug therapy in Guizhou Province, China.

Indexed as

Polymorphism, GeneticAdultAfricaAmino Acid SubstitutionAntimalarialsATP-Binding Cassette, Sub-Family C ProteinsChinaCohort StudiesCommunicable Diseases, ImportedDrug ResistanceFemaleHumansMalaria, FalciparumMaleMembrane Transport ProteinsMiddle AgedAntimalarialsATP-Binding Cassette, Sub-Family C ProteinsMdr1 protein, Plasmodium falciparumMembrane Transport ProteinsPfCRT protein, Plasmodium falciparumProtozoan ProteinsAntimalarial drugsHaplotypePlasmodium falciparumPolymorphismResistance

Identifiers

PMID32677899
PMCPMC7364468
OpenAlexW3043405293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.